£515.00

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India

Price data last checked 79 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 12 days • 12 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 26 January 2026 28 January 2026 31 January 2026 03 February 2026 06 February 2026

Price Distribution

Price distribution over 12 days • 1 price levels

Days at Price
12 days 0 3 6 9 12 £515 Days at Price

Price Analysis

Most common price: £515 (12 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 12 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Kinase Inhibitors in India
97% match

The 2023-2028 Outlook for Kinase Inhibitors in India

£515.00 11 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
97% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India
97% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 14 Jan 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
97% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India
97% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in India
97% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Insomnia Therapeutics in India
97% match

The 2023-2028 Outlook for Insomnia Therapeutics in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in India
97% match

The 2023-2028 Outlook for Lymphoma Treatments in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
97% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in India
96% match

The 2023-2028 Outlook for Over the Counter Drugs in India

£515.00 20 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India
96% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in India
96% match

The 2023-2028 Outlook for Antiviral Drugs in India

£515.00 29 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in India
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in India

£515.00 09 Feb 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in India
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Topical Vitiligo Therapeutics in India
96% match

The 2023-2028 Outlook for Topical Vitiligo Therapeutics in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in India
96% match

The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in India

£515.00 14 Jan 2026